Exploring how diet affects treatment for pancreatic cancer
Understanding the effects of dietary interventions on pancreatic ductal adenocarcinoma therapy cancer
['FUNDING_OTHER'] · VAN ANDEL RESEARCH INSTITUTE · NIH-10918267
This study is looking at how changing your diet might help improve treatment for pancreatic cancer, and it aims to give personalized food suggestions to help patients get better results from their therapies.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VAN ANDEL RESEARCH INSTITUTE (nih funded) |
| Locations | 1 site (GRAND RAPIDS, UNITED STATES) |
| Trial ID | NIH-10918267 on ClinicalTrials.gov |
What this research studies
This research investigates the impact of dietary interventions on the treatment of pancreatic ductal adenocarcinoma (PDAC), a highly aggressive cancer with limited options. It focuses on how diet can influence the tumor microenvironment and potentially enhance the effectiveness of cancer therapies. By understanding the molecular mechanisms behind the interactions between diet and cancer treatments, the research aims to provide tailored dietary recommendations that could improve patient outcomes. Patients may be involved in exploring how specific dietary changes can affect their treatment response.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with pancreatic ductal adenocarcinoma who are undergoing treatment.
Not a fit: Patients with other types of cancer or those not currently receiving treatment for pancreatic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment outcomes for patients with pancreatic cancer through personalized dietary recommendations.
How similar studies have performed: While dietary interventions in cancer treatment are being explored, this specific approach focusing on pancreatic cancer and its unique metabolic dependencies is relatively novel.
Where this research is happening
GRAND RAPIDS, UNITED STATES
- VAN ANDEL RESEARCH INSTITUTE — GRAND RAPIDS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LIEN, EVAN CHEN — VAN ANDEL RESEARCH INSTITUTE
- Study coordinator: LIEN, EVAN CHEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Anti-Cancer Agents, Cancer Biology, Cancer Drug, Cancer Model, Cancer Patient